跳至主要内容
临床试验/NCT02312193
NCT02312193已完成不适用

Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects

Neuromed IRCCS1 个研究点 分布在 1 个国家目标入组 95 人开始时间: 2015年1月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
95
试验地点
1
主要终点
Myogenic tone measured by micromyographic technique to evaluate small-artery morphology.

研究概览

简要总结

Aim of this study is to enhance the knowledge of myogenic tone alterations in hypertensive patients and to better understand the mechanisms controlling the myogenic tone. Evaluations will be performed through ex vivo studies of peripheral arterioles in human adipose tissue from lumbar muscle, isolated from biopsies. This will allow investigators to evaluate the myogenic function in response to progressive blood pressure increases, in order to correlate myogenic function to arterial hypertension and to the molecular mechanisms already identified in the preclinical models.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females between 30 and 70 years of age
  • Hypertensive patients: Patients with a previous diagnosis of hypertension
  • Normotensive patients: subjects without story of hypertension
  • Written informed consent

排除标准

  • Severe hypertension (eg, systolic >180 mm Hg, diastolic >110 mm Hg)
  • Manifested or suspected secondary hypertension (coarctation of the aorta, hyperaldosteronism, unilateral or bilateral renal artery stenosis, pheochromocytoma)
  • History of cardiac complications (previous acute myocardial infarction (AMI), unstabile angina, percutaneous transluminal coronary angioplasty (PTCA), coronary artery bypass grafting (CABG), congestive heart failure (NYHA II-IV))
  • Diabetes mellitus
  • Renal pathologies (creatinine clearance < 30 ml/min)
  • Severe hepatic dysfunction

结局指标

主要结局

Myogenic tone measured by micromyographic technique to evaluate small-artery morphology.

时间窗: 12 months

次要结局

未报告次要终点

研究者

发起方
Neuromed IRCCS
申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuseppe Lembo

MD, Ph

Neuromed IRCCS

研究点 (1)

Loading locations...

相似试验